January 08, 2025 11:00 AM Eastern Standard Time CARLSBAD, Calif.–(BUSINESS WIRE)–Nalu Medical, Inc. (“Nalu”), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use of Nalu PNS therapy in chronic pain patients is associated with lower healthcare resource utilization (HCRU) and a significant reduction in associated costs.,[…]
December 4, 2024 CARE to Lead® with Cynthia Corsetti Listen to the full podcast >> Cynthia Corsetti is joined on the Care to Lead podcast by Dr. Joseph Zabinski, Vice President and Head of Commercial Strategy and AI at OM1. With a PhD in Health Analytics and a Master’s in Engineering Management, Dr. Zabinski discusses[…]
Read the full press release >> ROSEMONT, Ill. (Oct. 30, 2024) — A new initiative by the American Academy of Dermatology aims to shed light on an often misunderstood and debilitating condition, hidradenitis suppurativa (HS). HS is a chronic progressive condition that can cause painful and boil-like bumps, particularly in a patient’s armpits, thighs, and groin.[…]
Pharmaceutical Executive October 25, 2024 Read the full article >> Despite a recent FDA Complete Response Letter issued to Lykos for midomafetamine capsules for the treatment of post-traumatic stress disorder, experts believe that the future is bright for psychedelic drugs that treat mental health conditions. On August 9, 2024, the FDA announced that it had[…]
Authority Magazine October 6, 2024 Read the full article >> Invest in training and upskilling — Ensuring teams are equipped with the necessary skillset to work alongside AI is critical for success and responsible use of the technology. This includes comprehensive training on the foundation of AI, implementing AI, and special use cases of AI in[…]
